Jazz Pharmaceuticals on Feb. 3 announced the acquisition of GW Pharmaceuticals for a total consideration of $7.
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) investors cheer the announcement that the drug maker achieved positive results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial …
Leerink Swann analysts were out today with favorable reports on pharmaceutical giant Gilead Sciences, Inc.(NASDAQ:GILD) and cannabis-based drug maker GW Pharmaceuticals PLC (NASDAQ:GWPH).
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the …
GW Pharmaceuticals plc (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced positive …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) ), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces that …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial …
